CIK: 0001727492 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value ($000): $520,168 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | VERONA PHARMA PLC | 1,436,878 | $135,900 | 26.1% | $16.60 | — | SPONSORED ADS | 925050106 |
| LQDA | LIQUIDIA CORPORATION | 8,118,892 | $101,161 | 19.4% | $5.57 | +165.8% | COM NEW | 53635D202 |
| EXEL | EXELIXIS INC | 1,525,730 | $67,247 | 12.9% | $19.42 | +105.8% | COM | 30161Q104 |
| AGIO | AGIOS PHARMACEUTICALS INC | 1,071,258 | $35,630 | 6.8% | $28.94 | +4.7% | COM | 00847X104 |
| — | MERUS N V | 656,999 | $34,558 | 6.6% | $46.55 | — | COM | N5749R100 |
| EOLS | EVOLUS INC | 3,341,970 | $30,780 | 5.9% | $10.58 | -3.3% | COM | 30052C107 |
| MLYS | MINERALYS THERAPEUTICS INC | 2,017,352 | $27,295 | 5.2% | $11.97 | +21.1% | COM | 603170101 |
| RVMD | REVOLUTION MEDICINES INC | 636,835 | $23,429 | 4.5% | $40.00 | -4.0% | COM | 76155X100 |
| ANIK | ANIKA THERAPEUTICS INC | 1,435,130 | $15,184 | 2.9% | $25.57 | -50.7% | COM | 035255108 |
| ABVX | ABIVAX SA | 1,674,400 | $12,809 | 2.5% | $7.07 | — | SPONSORED ADS | 00370M103 |
| — | Y-MABS THERAPEUTICS INC | 2,342,609 | $10,565 | 2.0% | $8.13 | — | COM | 984241109 |
| RZLT | REZOLUTE INC | 1,543,014 | $6,882 | 1.3% | $3.77 | -1.6% | COM NEW | 76200L309 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 638,908 | $5,725 | 1.1% | $5.90 | +57.9% | COM | 09058V103 |
| SLS | SELLAS LIFE SCIENCES GROUP I | 2,300,000 | $5,037 | 1.0% | — | — | Call | 81642T209 |
| — | VERRICA PHARMACEUTICALS INC | 9,239,119 | $4,898 | 0.9% | $0.65 | — | COM | 92511W108 |
| TYRA | TYRA BIOSCIENCES INC | 189,950 | $1,818 | 0.3% | $9.95 | -4.5% | COM | 90240B106 |
| AURA | AURA BIOSCIENCES INC | 200,000 | $1,252 | 0.2% | $5.85 | 0.0% | COM | 05153U107 |